CSCO
64
6
EMC
47
11
DRI
66
2
NVDA
54
5
MRK
63
3
TDC
70
3
IVZ
70
2
XYL
33
6
O
33
2
MA
55
4
MCHP
47
-8
PVH
32
2
A
43
-5
TEL
66
6
DHR
66
2
CCL
81
16
ADT
50
2
FITB
75
2
STX
69
2
CMS
60
-2
CSCO
64
6
EMC
47
11
DRI
66
2
NVDA
54
5
MRK
63
3
TDC
70
3
IVZ
70
2
XYL
33
6
O
33
2
MA
55
4
MCHP
47
-8
PVH
32
2
A
43
-5
TEL
66
6
DHR
66
2
CCL
81
16
ADT
50
2
FITB
75
2
STX
69
2
CMS
60
-2
Financhill
Back

Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
78

GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF

Last Price:
$132.59
Seasonality Move:
3.87%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
78
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) is a Buy

Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?

  • The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $132.56. The Score for GSLC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • GSLC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GSLC Stock Price Chart

What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?

  • The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $132.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GSLC is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

GSLC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 55.09 Buy
Chaikin Money Flow: 136561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.1 - 133.06) Buy
Bollinger Bands (100): (126.51 - 131.89) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

GSLC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 132.26 Buy
20-day SMA: 131.82 Buy
50-day SMA: 130.89 Buy
200-day SMA: 121.79 Buy
8-day EMA: 132.01 Buy
20-day EMA: 131.74 Buy
50-day EMA: 128.69 Buy
200-day EMA: 82.51 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):